You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 20, 2025

Global Blood Theraps Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Global Blood Theraps
International Patents:257
US Patents:11
Tradenames:1
Ingredients:1
NDAs:2

Drugs and US Patents for Global Blood Theraps

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Global Blood Theraps OXBRYTA voxelotor TABLET;ORAL 213137-001 Nov 25, 2019 DISCN Yes No 11,944,612 ⤷  Subscribe ⤷  Subscribe
Global Blood Theraps OXBRYTA voxelotor TABLET;ORAL 213137-001 Nov 25, 2019 DISCN Yes No 10,017,491 ⤷  Subscribe Y ⤷  Subscribe
Global Blood Theraps OXBRYTA voxelotor TABLET, FOR SUSPENSION;ORAL 216157-001 Dec 17, 2021 DISCN Yes No 10,722,502 ⤷  Subscribe Y ⤷  Subscribe
Global Blood Theraps OXBRYTA voxelotor TABLET;ORAL 213137-002 Oct 14, 2022 DISCN Yes No 9,018,210 ⤷  Subscribe Y Y ⤷  Subscribe
Global Blood Theraps OXBRYTA voxelotor TABLET;ORAL 213137-002 Oct 14, 2022 DISCN Yes No 10,806,733 ⤷  Subscribe Y ⤷  Subscribe
Global Blood Theraps OXBRYTA voxelotor TABLET;ORAL 213137-002 Oct 14, 2022 DISCN Yes No ⤷  Subscribe ⤷  Subscribe
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 6 of 6 entries

International Patents for Global Blood Theraps Drugs

CountryPatent NumberEstimated Expiration
Denmark 3102208 ⤷  Subscribe
Eurasian Patent Organization 201592212 ⤷  Subscribe
European Patent Office 3738434 ⤷  Subscribe
Mexico 358992 ⤷  Subscribe
Saudi Arabia 515361021 ⤷  Subscribe
South Korea 20150132146 ⤷  Subscribe
>Country>Patent Number>Estimated Expiration
Showing 1 to 6 of 6 entries

Supplementary Protection Certificates for Global Blood Theraps Drugs

Patent NumberSupplementary Protection CertificateSPC CountrySPC ExpirationSPC Description
2797416 32/2022 Austria ⤷  Subscribe PRODUCT NAME: VOXELOTOR ODER EIN TAUTOMER ODER PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1622 (MITTEILUNG) 20220215
2797416 C202230036 Spain ⤷  Subscribe PRODUCT NAME: VOXELOTOR O UN TAUTOMERO O SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/21/1622; DATE OF AUTHORISATION: 20220214; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/21/1622; DATE OF FIRST AUTHORISATION IN EEA: 20220214
2797416 CA 2022 00032 Denmark ⤷  Subscribe PRODUCT NAME: VOXELOTOR ELLER EN TAUTOMER ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1622 20220215
2797416 CR 2022 00032 Denmark ⤷  Subscribe PRODUCT NAME: VOXELOTOR ELLER EN TAUTOMER ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1622 20220215
2797416 PA2022517 Lithuania ⤷  Subscribe PRODUCT NAME: VOKSELOTORAS ARBA TAUTOMERAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA ; REGISTRATION NO/DATE: EU/1/21/1622 20220214
2797416 SPC/GB22/039 United Kingdom ⤷  Subscribe PRODUCT NAME: VOXELOTOR OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/21/1622(FOR NI) 20220215; UK FURTHER MA ON IPSUM 20220215
>Patent Number>Supplementary Protection Certificate>SPC Country>SPC Expiration>SPC Description
Showing 1 to 6 of 6 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.